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Abstract 
Extensive preoperative assessment of hepatic metastases is required in colon cancer 
patients. We report a case in whom the preoperative investigation by ultrasound scan 
and contrast-enhanced computed tomography revealed numerous cystic lesions of the 
liver, suspicious of von Meyenburg complex. Magnetic resonance and magnetic 
resonance cholangiographic images demonstrated typical features of von Meyenburg 
complex. Further Resovist-enhanced magnetic resonance imaging detected two 
hemangiomas in addition to the multiple cystic lesions. So-called Kupffer cell imaging 
strongly helped the detection of these hemangiomas, and a combination of various 
magnetic resonance pulse sequences was of great value for the differential diagnosis of 
cystic lesions and hemangiomas. In cases in whom conventional imaging studies fail to 
give a definite diagnosis, such as in the present case, superparamagnetic iron 
oxide-enhanced magnetic resonance imaging is meaningful for adequate preoperative 
staging. 
 
Introduction 
Preoperative staging is crucial for the management of cancer patients. In colon cancer 
patients, extensive preoperative assessment of metastatic disease, especially liver 
metastases, plays a key role in the adequate clinical decision of surgical treatment. A wide 
range of imaging modalities, including ultrasound scan (US), computed tomography 
(CT), CT during arterial portography (CTAP) and magnetic resonance imaging (MRI),  
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are available for the detection of hepatic metastases. In terms of the ability to detect 
metastases in otherwise normal liver, high diagnostic ability can be expected in each of 
the above techniques. However, when multiple focal lesions such as cysts, biliary 
hamartomas and hemangiomas exist as the background noise, the conventional screening 
strategy, which includes US, CT or non-enhanced MRI, will not be sufficient for the 
accurate detection of metastatic lesions in most of the cases. 
Superparamagnetic iron oxide (SPIO), such as ferumoxides and ferucarbotrans 
(Resovist), has recently been developed as a liver-specific MRI contrast agent to improve 
the detectability of hepatic tumors [1, 2]. SPIOs contain iron particles which are 
phagocytosed by Kupffer cells and the reticuloendothelial system in normal liver and in 
most benign lesions. Since Kupffer cells are not present in metastatic lesions, 
administration of the contrast agent will result in improvement of the mean lesion to liver 
contrast ratio, resulting in an increased lesion conspicuousness on MRI. Thus, 
SPIO-enhanced MRI provides excellent visualization of liver metastatic lesions in the 
preoperative assessment of colorectal cancer patients [3]. 
We describe a patient with sigmoid colon cancer in whom preoperative assessment by 
US and contrast-enhanced CT showed numerous cystic lesions of the liver, suspicious of 
von Meyenburg complex, making difficult the visualization of other lesions. 
Resovist-enhanced MR imaging greatly helped the preoperative assessment. 
Case Report 
A 56-year-old man was referred to our institution with advanced carcinoma of the sigmoid colon. 
Preoperative assessment of metastatic disease was performed by contrast-enhanced CT scan of the 
thorax and the abdomen. Contrast-enhanced CT demonstrated multiple, non-enhancing, irregularly 
defined hypodense structures (<1.5 cm) in both lobes of the liver (fig. 1a). Abdominal US also revealed 
many hypoechoic and hyperechoic lesions scattered in both hepatic lobes (fig. 1b). Although the CT and 
US findings were highly suspicious of multiple bile duct hamartoma, also known as von Meyenburg 
complex, to exclude disseminated liver metastases, MR examination was performed. MRI confirmed the 
presence of multiple hypointense and hyperintense hepatic nodules, on T1-weighted gradient echo 
images and T2-weighted fast spin echo images, respectively (fig. 2a, b). On heavily T2-weighted images, 
the signal intensity increased (fig. 2c). Resovist-enhanced T1-weighted image showed no enhancement 
of these lesions (fig. 3c). These findings are characteristic MR features of von Meyenburg complex [4–
6]. Further Resovist-enhanced images revealed two different lesions in hepatic segment VII and V, in 
addition to the numerous cystic lesions suspicious of von Meyenburg complex. Fast spoiled gradient 
echo sequence with a long TE and a large flip angle (so-called Kupffer cell images) detected two 
enhanced lesions except for cystic lesions with isointensity on this sequence (fig. 3b). These two lesions 
showed nodular peripheral enhancement similar to aortic attenuation on contrast-enhanced CT 
(fig. 3a). These hemangiomas and the multiple cystic lesions were both hypointense on T1- and 
hyperintense on T2-weighted images. Therefore, detection and characterization of such lesions by 
unenhanced MRI is a difficult matter. After injection of Resovist, these two types of lesions revealed iso- 
and hypointensity, respectively, on T1-weighted images (fig. 3c) and iso- and hyperintensity, 
respectively, on T2-weighted images (fig. 3d). These findings, although not characteristic, helped to give 
the final diagnosis of hemangiomas. Resovist-enhanced MR findings and other imaging modalities 
provided no obvious evidence of metastatic lesions. 
The patient received sigmoidectomy. The liver showed many tiny cystic lesions on its surface, and 
intraoperative US confirmed the presence of two hemangiomas, but no metastases. The postoperative 
course was uneventful, and the follow-up CT 18 months later showed neither change in the findings of 
hepatic lesions nor recurrence. Follow-up with imaging modalities including SPIO-enhanced MRI is 
scheduled.  
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Discussion 
Resectable liver metastases are found in 3% of patients with colorectal cancer [7]. If a 
curative resection is performed, a 5-year survival rate of 25–30% has been shown in a 
large number of studies [8]. Therefore extensive preoperative investigation for liver 
metastases is required for the decision of the adequate treatment strategy. Previous 
studies have proved that SPIO definitely improves the detectability of hepatic metastases 
on unenhanced MR images up to the level of CTAP [3]. In our institution, US and 
contrast-enhanced CT are the first choice for screening of liver metastases, and 
SPIO-enchanced MRI and intraoperative US are performed additionally when necessary. 
In the present case, the liver was diffusely occupied by cystic lesions, which led to the 
suspicion of von Meyenburg complex. Von Meyenburg complex, also known as multiple 
bile duct hamartomas or biliary hamartomas, is a benign malformation of the bile ducts 
in which the embryonal bile duct network has failed to involute. The US appearance of 
von Meyenburg complex varies between hypoechoic and hyperechoic lesions [5, 6], and 
some cases of von Meyenburg complex have been noted to show homogenous 
enhancement on contranst-enhanced CT [5, 9]. Therefore, it is quite difficult to exclude 
other hepatic lesions, such as tumor metastasis, by US and CT. On MRI, the signal 
intensity on T2-weighted image progressively decreases from cysts and biliary 
hamartomas to hemangiomas and metastases, but the signal intensity, in most cases, 
overlaps, resulting in an inconclusive study [10]. Further investigation is required on how 
to improve the detection ability of metastatic lesions behind the background noise of 
numerous cysts in oncologic patients, such as in the present case. 
The most effective MR pulse sequence for the detection of metastatic lesions is not a 
fast spin echo T2-weighted sequence, but a gradient echo sequence with a long TE, 
so-called T2*-weighted sequence [11]. On T2*-weighted images, both cysts and 
metastases show hyperintensity compared to the normal hepatic parenchyma. If 
T2*-weighted sequence is modified with a larger flip angle, cysts and biliary hamartomas 
become isointense compared to liver parenchyma, whereas metastases and hemangiomas 
remain hyperintense because of relatively short T1. This modified sequence, which is 
called ‘Kupffer (cell) imaging’, may be more suitable than the original T2*-weighted 
sequence for the detection of lesions hidden among cysts [12]. Indeed, Kupffer cell 
imaging was valuable to extract two hemangiomas from multiple cystic lesions in this 
patient. 
However, when evaluating metastatic tumors, it is sometimes difficult to differentiate 
solid metastatic tumors from hemangiomas because both lesions shows high intensity on 
Kupffer cell images. Recently, in addition to the lesion sensitivity, the lesion specificity 
can also be improved by combination of various MR pulse sequences, including 
T2-weighted sequence and post-contrast T1-weighted sequence with Kupffer cell imaging 
[13–15]. Hemangiomas show high intensity on pre-contrast T2-weighted image, and a 
significant signal drop is observed on post-contrast T2-weighted images. On 
post-contrast T1-weighted image, hemangiomas show iso- or hyperintensity. On the 
other hand, the intensity of metastases on pre-contrast T2-weighted images is usually 
lower than that of hemangiomas, and the signal intensity does not change on 
post-contrast T2-weighted image [13, 14]. Metastases show hypointensity with the 
well-known ‘ring enhancement’ on post-contrast T1-weighted image [15]. In our patient, 
two different lesions were diagnosed as hemangiomas with high intensity on pre-contrast 
T2-weighted image and a characteristic signal drop on post-contrast T2-weighted image.  
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In this case, the biliary duct hamartomas were not histopathologically proven and the 
hemangioma was neither radiologically nor pathologically proven and the metastases 
were not excluded on solid base of biopsy, but the follow-up period was 18 months. 
During this follow-up period, the patient had no recurrence, and we are confident that 
these lesions are not metastatic lesions. Moreover, in Japan, it is not ethically feasible to 
perform biopsy of lesions suspected of hamartomas or hemangioma, and consequently 
the pathological diagnosis of such lesions is unfeasible. 
In conclusion, Resovist-enhanced MR imaging was useful for the detection and 
characterization of hepatic lesions and preoperative staging of colorectal cancer. In cases 
where multiple focal lesions, such as cysts and biliary hamartomas, exist as the 
background noise, SPIO-enhanced MRI including Kupffer cell imaging may improve the 
sensitivity and specificity of detection, especially of metastasic lesions. In cases in whom 
the conventional imaging studies fail to give a diagnosis, Resovist-enhanced MR imaging 
with various sets of pulse sequence is recommended for the differential diagnosis of 
benign and malignant hepatic lesions. 
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Fig. 1. A 56-year-old man with colon cancer and multiple cystic lesions suspicious of von Meyenburg 
complex. a Contrast-enhanced CT shows multiple small cystic lesions in both hepatic lobes. No 
enhancement is seen. b Hepatic US shows many hypoechoic and hyperechoic lesions scattered 
throughout the liver. 
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Fig. 2. MR findings. a T1-weighted gradient echo image shows multiple hypointense liver lesions. 
b T2-weighted fast spin echo image shows multiple hyperintense hepatic nodules. c Heavily 
T2-weighted image shows that the signal intensity of the lesions further increased. 
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Fig. 3. Coexistence of multiple cystic lesions (arrow) and a hamangioma in hepatic segment VII 
(arrowhead). a Contrast-enhanced CT. b Resovist-enhanced fast spoiled gradient echo sequence with a 
long TE and a large flip angle (i.e. Kupffer cell image) (TR/TE/FA: 150/8.8/60°). c SPIO-enhanced 
T1-weighted MR image. d SPIO-enhanced T2-weighted MR image. A hemangioma in hepatic 
segment VII is visible as a globular hyperdense lesion on contrast-enhanced CT image (a). On Kupffer 
cell image (b), this lesion becomes easily detectable because diffuse cystic lesions become isointense to 
liver parenchyma. The hemangioma shows almost isointense to hepatic parenchyma on T1-weighted 
image (c) and is seen isointense to kidney on post-contrast (d) T2-weighted images, respectively. 
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